Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -
Clinical trial NCT03819010 · COMPLETED
Trial details
- NCT number
- NCT03819010
- Sponsor
- MedSIR
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2019-07-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.